In addition, Hosono et al. [15] identified a novel lncRNA, THOR, and proved that THOR functioned as an oncogene and promoted tumor progression via interacting with insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1). This evidence concerns the gene IGF2BP1 and neoplasm.